Roche's Virtual Pipeline Event

Phase 2 results of the bispecific VEGF/Ang2 antibody RG7716 in diabetic macula edema presented at Angiogenesis 2018

Please register to access the replay* *Privacy notice

Check out the replay here

Investors

Past IR Events

View more Events

Downloads

Presentation

PDF

Related links

GovernanceAbout Roche

Our corporate governance principles focus on sustainable value creation and prescribe a culture that recognises standards of good corporate governance and policy of transparent communication.

Product Development PortfolioSolutions

Discover our pipeline of Pharmaceutical and Diagnostics developments

Frequently Asked QuestionsInvestors

We answer the Roche investors-related most frequently asked questions